Elevation of stromal cell-derived factor 1 and C-X-C chemokine receptor type 4 in white matter damage treatment with recombinant human erythropoietin and human umbilical cord mesenchymal stem cells in a rat model of preterm birth,International Journal of Developmental Neuroscience

当前位置： X-MOL 学术 › Int. J. Dev. Neurosci. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Elevation of stromal cell-derived factor 1 and C-X-C chemokine receptor type 4 in white matter damage treatment with recombinant human erythropoietin and human umbilical cord mesenchymal stem cells in a rat model of preterm birth
International Journal of Developmental Neuroscience ( IF 1.8 ) Pub Date : 2020-03-25 , DOI: 10.1002/jdn.10021
Liping Yin _{1,

2} , Shiyu Wang ₃ , Ning Zhang _{1,

2} , Xiang Bai ₄ , Jiali Xie _{1,

2} , Quan Wen _{1,

2} , Li Huang _{1,

2} , Lijuan Qian _{1,

2} , Li Jiang _{1,

2}

Affiliation

To investigate the role of stromal cell‐derived factor 1 (SDF‐1) and C‐X‐C chemokine receptor type 4 (CXCR‐4) in the premature brain with white matter damage (WMD) undergoing treatment with human umbilical cord mesenchymal stem cells (hUC‐MSCs) and recombinant human erythropoietin (rhEPO).

中文翻译：

在早产大鼠模型中用重组人促红细胞生成素和人脐带间充质干细胞治疗白质损伤中基质细胞衍生因子 1 和 CXC 趋化因子受体 4 的升高

探讨基质细胞衍生因子 1 (SDF-1) 和 C-X-C 趋化因子受体 4 型 (CXCR-4) 在接受人脐带间充质干治疗的白质损伤 (WMD) 早产脑中的作用细胞（hUC-MSCs）和重组人促红细胞生成素（rhEPO）。

更新日期：2020-03-25

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>